Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206992
Company: GLAND

Products on ANDA 206992

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MESNA	MESNA	100MG/ML	INJECTABLE;INTRAVENOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 206992

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/18/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/06/2019	SUPPL-3	Labeling-Package Insert		Label is not available on this site.
09/06/2019	SUPPL-1	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 206992

MESNA

INJECTABLE;INTRAVENOUS; 100MG/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MESNA	MESNA	100MG/ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	220518	EUGIA PHARMA
MESNA	MESNA	100MG/ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	075811	FRESENIUS KABI USA
MESNA	MESNA	100MG/ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	206992	GLAND
MESNA	MESNA	100MG/ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	075739	HIKMA
MESNA	MESNA	100MG/ML	INJECTABLE;INTRAVENOUS	Prescription	No	AP	090913	SAGENT PHARMS INC
MESNEX	MESNA	100MG/ML	INJECTABLE;INTRAVENOUS	Prescription	Yes	AP	019884	BAXTER HLTHCARE